DB

Druid BioVentures

North America, Pennsylvania, United States, Philadelphia

Description

Druid BioVentures is a principal investment firm specializing in investments in novel drug with a focus on virtual companies.

Investor Profile

Druid BioVentures has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Therapeutics.

Stage Focus

  • Series A (33%)
  • Series C (33%)
  • Series B (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Druid BioVentures frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
SC
North America, California, United States, San Francisco
Co-Investments: 2
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 3
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 3
GP
North America, Illinois, United States, Chicago
Co-Investments: 1
Cowen Group
North America, New York, United States, New York
Co-Investments: 1
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 2
Baxter Ventures
North America, Illinois, United States, Deerfield
Co-Investments: 1
Latterell Venture Partners
North America, California, United States, San Francisco
Co-Investments: 3
P
North America, Illinois, United States, Northbrook
Co-Investments: 3

What are some of recent deals done by Druid BioVentures?

Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series CDec 3, 2014
Amount Raised: $80,000,000
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series BDec 17, 2012
Amount Raised: $38,000,000
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series AMay 11, 2011
Amount Raised: $18,000,000